iShares US Pharmaceuticals ETF (IHE) — ()
Key Metrics
News
5 ETFs to Buy for January
Published: by:
Sentiment: Positive ()
5 ETFs to buy in January: momentum, small caps, chips, defense and healthcare shine as markets rally early in 2026 -- IWM, MTUM, SMH, XAR and IHE.
Read More
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends
Published: by:
Sentiment: Positive ()
XLV and similar healthcare ETFs are gaining momentum as strength in biotech, increased AI adoption, and rising defensive demand position the sector for year-end leadership.
Read More
Pharma's $370B Bet on America: The ETF Plays for 2026
Published: by:
Sentiment: Positive ()
Pharma ETFs like IHE are gaining traction as drugmakers pledge $370 billion to U.S. projects, fueling a new investment super-cycle heading into 2026.
Read More
3 Dividend ETFs to Buy and Hold for Life if the Market Crashes
Published: by:
Sentiment: Positive ()
Dividend ETFs may be the best investment you can make today.
Read More
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal
Published: by:
Sentiment: Positive ()
Pharma ETFs like IHE are poised to surge as the UK-US zero-tariff deal raises UK drug prices and strengthens major U.S. players' outlook.
Read More
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
Published: by:
Sentiment: Positive ()
Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.
Read More
Pharma ETF (IHE) Hit a 52-Week High
Published: by:
Sentiment: Positive ()
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high.
Read More
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
Published: by:
Sentiment: Negative ()
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on …
Read More
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
Published: by:
Sentiment: Negative ()
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Read More
IHE: Healthcare Dashboard For June
Published: by:
Sentiment: Positive ()
The healthcare providers industry is undervalued by about 22% versus 11-year averages, while pharma/biotech and life science tools trade near historical baseline in valuation. IHE ETF offers exposure to U.S. …
Read More
ETFs on the Move Post U.S.-China Trade Deal
Published: by:
Sentiment: Positive ()
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
Read More
Pharma ETFs in Focus on Trump's Drug Price Overhaul
Published: by:
Sentiment: Negative ()
Trump's plan to slash the price of prescription drugs by 30% put pharma ETFs in focus.
Read More
A Look at Pharma ETFs After Strong Q1 Earnings
Published: by:
Sentiment: Positive ()
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Read More